Month: January 2013

Amyvid (Florbetapir F18) in injectable solution gets approval in the European Union for use in the diagnosis of patients with cognitive impairment Alzheimers disease and other causes.

Amyvid (Florbetapir F18) in injectable solution gets approval in the European Union for use in the diagnosis of patients with cognitive impairment Alzheimer’s disease and other causes. Amyvid is the first and only indicated diagnosis for testing PET agent that allows you to identify the density of the plate beta-amyloid in the brain neuritic. Indianapolis (USA)UU), January 2013.- Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., wholly owned subsidiary of Lilly, have announced that the European Commission has approved Amyvid (Florbetapir F18) solution for perfusion as a radiopharmaceutical indicated diagnosis for PET (positron emission tomography) test that can identify the density of the plate beta-amyloid in the brain of adult patients neuritic with cognitive impairment, which is evaluating a possible diagnosis of Alzheimer’s disease and other causes of cognitive impairment. Amyvid should be used in conjunction with clinica1 evaluation. Amyvid joins the amyloid plaques, one of the characteristic neuropatologicas of the of Alzheimer disease (ad) (2,3,4) and detected using PET imaging of the brain.(1) Amyvid is the first and only diagnostic tool adopted by the European Union showing the presence or absence of density of plaques of beta-amyloid in the brain neuritic ”, says Diane Bakaysa, international head of Amyvid Lilly. Amyvid, along with a clinical evaluation, can be an important aid to doctors who treat patients with cognitive impairment. It is important because it is estimated...

Read More

The maintenance of human assisted reproduction in the basic common healthcare portfolio of the national health system is an essential piece to keep the rate of 3.5 per cent of births annual turned by these techniques.

Maintenance of the human assisted reproduction in the basic common healthcare portfolio of the national health system is an essential piece to keep the rate of 3.5 per cent of births annual turned by these techniques. Association for the study of the biology of the reproduction (ASEBIR) advocates for these methods to mitigate the decline in pregnancies and births collected in the latest survey of hospital morbidity. Spain, January 2013.- Association for the study of the biology of the reproduction (ASEBIR) wants to highlight the important role that may play assisted human reproduction: in vitro fertilization and other techniques related to increase the number of pregnancies in our country. if the State promote assisted reproduction and fertilization in vitro, the rate of registered pregnancies would mitigate the reduction of pregnancies and deliveries in 2011 ”, points Manual Ardoy, President of ASEBIR. In this sense, worth noting that, according to figures from the last survey of hospital morbidity, recently published, in 2011 occurred nearly 4.7 million higher, 1.1% less than in 2010 (4.720.545), which means the third consecutive number of high annual decline. This figure comes motivated, once again, by the decrease in episodes of pregnancy and childbirth, which shrank 3.5% over the previous year. In this context, relevance special more than 86,000 cycles – 55,000 of In Vitro Fertilization and 31,000 of Artificial insemination – which, according to the...

Read More

Dolutegravir is an effective option to treat HIV infection.

Dolutegravir is an effective option to treat HIV infection. The drug in phase 3 of clinical research is as effective and safe as raltegravir and offers more resistance the mutations of the virus. a new drug against the virus of the AIDS (HIV-1), called dolutegravir, Spain, January of 2013- a multicenter study published in the journal The Lancet compared with raltegravir, another antiretroviral of the same family marketed since 2007. The study concludes that the two drugs have the same efficacy and safety. In other studies, dolutegravir has proved to be superior to the treatments of reference, more resistant to mutations in HIV-1, does not need to be enhanced with other medications and can manage in a single daily dose. This makes the dolutegravir an effective option to treat HIV-1 infection. Researchers of the Institute of biomedical research of Bellvitge (IDIBELL) at the Hospital Universitario de Bellvitge have participated in the study. Daniel Podzamczer, program director of HIV/AIDS of the service of infectious diseases of the Bellvitge HU and researcher at the IDIBELL, who participated in the study. Both dolutegravir and raltegravir are part of the family of integrase inhibitors, a group of drugs that block an enzyme the virus involved in your replication process. This group of antiretroviral drugs inhibit the virus more quickly, are well tolerated and have few interactions with other medications. Raltegravir was the first...

Read More

Success in the mobile phone campaign collected by fraternity Muprespa in support of the AEPM.

Success in the “mobile phones campaign” as collected by fraternity Muprespa in support of the AEPM. the mutual Muprespa fraternity has collected 881 mobile phones for the solidarity campaign of support to the Spanish Association of pathologies mitochondrial (AEPM). This initiative began on 13 September and ended at the beginning of December. Spain, January of 2013. The purpose of this campaign was to collect funds for research on new drugs that improve the quality of life for people affected by mitochondrial diseases. A disease that affects ever closer to the adult population but they are still children affected principals. Mitochondrial diseases are disorders arising due to the deficiency of one or more proteins localized in the mitochondrion and involved in metabolism; its origin can be found by mutations in mitochondrial DNA or by mutations in nuclear genes encoding proteins involved in the proper functioning of the mitochondria. Depending on the affected cells, symptoms can generate: loss of motor control, muscle weakness, pain, gastrointestinal disorders, difficulty in swallowing, retardation in growth, heart disease, liver disease, diabetes, respiratory complications, crisis, Visual and auditory problems, lactic acidosis, delays in development, susceptibility to infectionfertility problems and hormonal problems. fraternidad Muprespa has managed to collect for this purpose 881 terminals; a campaign that has enjoyed great acceptance and involving employees and mutual. Department of Corporate Social responsibility has been commissioned to organize and manage...

Read More

The WTO renews the composition of its Central Committee of deontology.

The WTO renews the composition of its Central Committee of deontology. Spain, January 2013.- the General Assembly of the Spanish Medical Association (WTO), in its meeting of last Saturday, January 19, has undertaken the renovation of five of the 12 members that make up the Central Ethics Commission of the WTO, after the convocation of elections announced on November 13, 2012. On a total of 14 candidates presented a proposal from different colleges of physicians, have been chosen by vote of the Assembly: Maria Castellano Arroyo, Professor of forensic medicine, proposed by the College of physicians of Granada (37 votes); Antonio Labad, psychiatrist, proposed by the College of physicians of Tarragona (36 votes); Julio García Guerrero, medical prison, proposed by the College of physicians of Castellón (31 votes); Joan Monés Xiol, gastroenterologist, proposed by the medical schools Council of Catalonia (27 votes); and Manuel García del Río, pediatrician, proposed by the College of physicians of Malaga (21 votes). Of these five members, three renewed their stay by another four years on the Commission, such as the Spanish doctors, García Guerrero and Mones. New addition are, therefore, doctors Labad and Garcia del Rio. “Once elected the five new members, they will pass to take possession of his charge, and then held a plenary session to appoint its new Permanent Committee, comprising the President, a Secretary and two vowels”. The Central...

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips